CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS ArticleZyryanov S.K., Dyakov I.N.Качественная клиническая практика. 2019. С. 23-32
MEDICATION ERRORS ASSOCIATED WITH BETA-LACTAM ANTIBIOTICS: ANALYSIS OF RUSSIAN SPONTANEOUS REPORTING DATABASE ArticleKuzmina A.V., Asetskaya I.L., Polivanov V.A., Zyryanov S.K.Antibiotiki i Khimioterapiya. Том 64. 2019. С. 48-53
COMPARATIVE PHARMACOECONOMICS OF BX IN THE TREATMENT OF PATIENTS WITH UNCONTROLLED MODERATE AND SEVERE ATOPIC ASTHMA IN THE RUSSIAN HEALTH CARE SETTING ArticleZyryanov S., Dyakov I.Value in Health. Том 22. 2019.
CARDIOVASCULAR COMPLICATIONS OF IMMUNE CHECKPOINT INHIBITORS ArticleKulieva A.A., Emelina E.I., Gendlin G.E., Nikitin I.G., Zyryanov S.K., Varentsov S.I., Zakharova I.I.Качественная клиническая практика. 2019. С. 55-65
GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE ArticleTkacheva O.N., Belenkov Y.N., Karpov Y.A., Zyryanov S.K.Kardiologiia. Том 59. 2019. С. 54-63
QUANTIATIVE ANA QUALITATIVE ASSESSMENT OF THE RANGE OF ANTIASTHMA MEDICINES AVAILABLE TO RUSSIAN CONSUMERS ArticleIvanov D.A., Kubaeva M.B., Zyryanov S.K.Фармакоэкономика: теория и практика. Том 7. 2019. С. 38-39
ABDOMINAL INFECTION. ANALYSIS, COMPARISON AND APPROACHES TO ANTIBIOTIC THERAPY: RUSSIAN AND INTERNATIONAL EXPERIENCE AND RECOMMENDATIONS ArticleRodoman G.V., Zyryanov S.K., Romashov O.M., Ivzhits M.A., Putsman G.A., Ionidi P.V., Kosenko O.A., Chenkurov M.S.Хирург. 2019. С. 45-59
CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER: INDIVIDUAL THERAPY AND ITS PATHOGENETIC BACKGROUND ArticleBobrova O.P., Shnayder N.A., Dychno Y.A., Zyryanov S.K., Petrova M.M.Russian Open Medical Journal. Том 8. 2019.
MODELING OF THE IMPACT OF BIOLOGICAL DRUGS IN THE ECONOMIC BURDEN OF SEVERE ASTHMA ArticleZyryanov Sergey, Dyakov Ilya, Karpov OlegКачественная клиническая практика. 2019. С. 4-12
ВОЗРАСТНЫЕ ОСОБЕННОСТИ ФАРМАКОКИНЕТИКИ ЦИПРОФЛОКСАЦИНА У ДЕТЕЙ, БОЛЬНЫХ МУКОВИСЦИДОЗОМ ArticleКондратьева Е.И., Кондакова Ю.А., Зырянов С.К., Бондарева И.Б., Воронкова А.Ю., Шерман В.Д., Мельяновская Ю.Л.Клиническая микробиология и антимикробная химиотерапия. Том 21. 2019. 37 с.
THE PHARMACOKINETIC OF THE MAIN ORAL ANTIBIOTICS IN CHILDREN WITH CYSTIC FIBROSIS ArticleKondakova Y., Kondratyeva E., Zyryanov S., Bondareva I., Sherman V., Melyanovskaya Y.EUROPEAN RESPIRATORY JOURNAL. Том 54. 2019.
AGE PECULIARITIES OF PHARMACOTHERAPY WITH AMOXICILLIN PREPARATIONS IN CHILDREN WITH CYSTIC FIBROSIS ArticleKondratieva E.I., Kondakova Y.A., Zyryanov S.K., Bondareva I.B., Voronkova A.Y., Sherman V.D., Melyanovskaya Y.L., Odinayeva N.D., Dronov I.A.Pediatriya - Zhurnal im G.N. Speranskogo. Том 98. 2019. С. 179-188
MODERN APPROACHES TO IMPROVING THE EFFECTIVENESS OF ANTIBIOTIC THERAPY IN PERINATOLOGY: LOCAL EXPERIENCE ArticleKazanova A.M., Zyryanov S.K., Ivzhits M.A., Kruglov A.N., Kutsaya K.O., Chenkurov M.S.Качественная клиническая практика. 2019. С. 66-74
THE EFFECT OF OPRM1, ABCB1, IL1B, PTGS2, LOC 541472 GENE POLYMORPHISM ON THE VARIABILITY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER ArticleBobrova Olga, Schnider Natalya, Zyryanov Sergey, Dmitrenko Diana, Zobova Svetlana, Zukov RuslanКачественная клиническая практика. 2019. С. 53-59
THERAPEUTIC DRUG MONITORING OF LEVETIRACETAM IN NEWBORNS ArticleBondareva I.B., Ivzhits M.A., Zyryanov S.K., Chenkurov M.S.Анналы клинической и экспериментальной неврологии. Том 13. 2019. С. 65-76
PHARMACOLOGY IN SPECIAL POPULATIONS: EXTREME AGE ArticleRomanov B.K., Zyryanov S.K.Качественная клиническая практика. 2019. С. 70-74
PHARMACOKINETICS OF ANTI-BACTERIAL PREPARATIONS IN CYSTIC FIBROSIS IN CHILDREN ArticleKondakova Y.A., Voronkova A.Y., Zyryanov S.K., Bondareva I.B.Сибирское медицинское обозрение. 2019. С. 5-13
PHARMACOECONOMIC EVALUATION OF CEFTOLOSAN + TASOBACTAM IN THE TREATMENT OF COMPLICATED NOSOCOMIAL INTRA-ABDOMINAL INFECTIONS ArticleZyryanov S.K., Dyakov I.N., Khachatryan N.N.Качественная клиническая практика. 2019. С. 55-69
CLINICAL AND ECONOMIC ANALYSIS OF THE AXITINIB AS A SECOND-LINE TARGET THERAPY FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA ArticleZyrianov S.K., Diakov I.N.Medical Technologies. Assessment and Choice. Том 36. 2019. С. 59-68
CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH ArticleTolkushin A.G., Zyryanov S.K., Pogudina N.L., Davydovskaya M.V.FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 11. 2019. С. 48-60
BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN COMPARISON WITH ANTIRE-SORPTIVE DRUGS IN SEVERE OSTEOPOROTIC PATIENTS ArticleDiakov I.N., Belaya Z.E., Zyrianov S.K., Mazurov V.I.Medical Technologies. Assessment and Choice. 2019. С. 71-80
EXTRACELLULAR DNA AND PLASMA NUCLEASE ACTIVITY EFFECT ON THE COURSE OF THE MICROBIAL INFLAMMATORY PROCESS IN THE RESPIRATORY TRACT IN CYSTIC FIBROSIS ArticleKondratieva E.I., Kondakova Yu.A., Kostyuk S.V., Ershova E.V., Zyryanov S.K., Melyanovskaya Yu.L., Voronkova A.Yu., Sherman V.D., Shadrina V.V.Journal of Bioinformatics and Genomics. 2018. 2 с.
CLINICAL CASE OF NON-IMMUNE HYDROPS FETALIS CONGENITAL SYPHILIS ATPRETERMINFANT ArticleShulakova O.A., Karabanov A.M., Zyryanov S.M., Gurevitch K.G.Неонатология: новости, мнения, обучение. 2018. С. 83-87
РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ "ЭМПИРИЧЕСКАЯ АНТИБАКТЕРИАЛЬНАЯ ТЕРАПИЯ ИНФЕКЦИЙ ДЫХАТЕЛЬНЫХ ПУТЕЙ С УЧЕТОМ ФАКТОРОВ РИСКА РЕЗИСТЕНТНОЙ ФЛОРЫ" ArticleКозлов Р.С., Зырянов С.К., Синопальников А.И., Рязанцев С.В., Стырт Е.А.Справочник поликлинического врача. 2018. С. 28-32
ПРОГНОЗНЫЙ ЭКОНОМИЧЕСКИЙ ЭФФЕКТ ПРИМЕНЕНИЯ АЛИРОКУМАБА У ПАЦИЕНТОВ С ГИПЕРХОЛЕСТЕРИНЕМИЕЙ И ВЫСОКИМ СЕРДЕЧНО-СОСУДИСТЫМ РИСКОМ ArticleЗырянов С.К., Дьяков И.Н.Клиническая фармакология и терапия. Том 27. 2018. С. 90-96
PHARMACOEPIDEMIOLOGY OF ANTIBACTERIAL DRUGS FOR PRETERM INFANTS ArticleDyrina K.S., Uvarova E.S., Kutsaya K.O., Zyryanov S.K., Zyryanov S.K.Клинические и теоретические аспекты современной медицины. 2018. 69 с.
HEALTH TECHNOLOGY ASSESSEMENT OF THE FIXED COMBINATION OF INSULIN GLARGINE 100 UI/ML AND LIXISENATIDE IN THE TREATMENT INTENSIFICATION OF DIABETES MELLITUS TYPE 2 ArticleZiryanov S.K., Dyakov I.N.Качественная клиническая практика. 2018. С. 4-13
ТЕРАПИЯ БРОНХИАЛЬНОЙ АСТМЫ У ДЕТЕЙ: ИНГАЛЯЦИОННЫЕ ГЛЮКОКОРТИКОСТЕРОИДЫ VS. АНТАГОНИСТЫ ЛЕЙКОТРИЕНОВЫХ РЕЦЕПТОРОВ (ОБЗОР ЛИТЕРАТУРЫ) ArticleПереверзев А.П., Зырянов С.К., Ушкалова Е.А., Чельцов В.В.Consilium Medicum. Том 20. 2018. С. 40-44
CLINICAL AND ECONOMIC EVALUATION OF USING FIXED DOSE DUAL BRONCHODILATOR COMBINATION TIOTROPIUMOLODATEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ArticleZyryanov S.K., Galatonova Y.A.Медицинский совет. 2018. С. 61-65
PHARMACOECONOMICS EXPEDIENCY OF APPLICATION OF THE COMBINED PREPARATION OF VEZOMNI IN COMPARISON WITH A COMBINATION OF TAMSULOSIN AND SOLIFENACIN IN THE FORM OF MONOPREPARATIONS ArticleZyryanov S.K., Dyakov I.N.Качественная клиническая практика. 2018. С. 35-40
METHODS OF PHARMACOLOGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION CURRENT APPROACHES TO THE PATIENTS MANAGEMENT ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Kardiologiia. Том 58. 2018. С. 82-93
PRINCIPLES OF SELECTION AND DOSING OF ANTIBACTERIAL AGENTS IN PATIENTS WITH HEPATIC FAILURE ArticleUshkalova E.A., Zyryanov S.K., Pereverzev A.P.Хирург. 2018. С. 75-88
PHARMACOECONOMIC ANALYSIS OF FLEXIBLE-DOSE ADMINISTRATION REGIMEN OF XEOMINE® IN PATIENTS WITH FOCAL DYSTONIA ArticleCheberda A.E., Belousov D.Yu., Zyryanov S.K.Качественная клиническая практика. 2018. С. 53-65
MODERN MASKS OF INFECTIOUS ENDOCARDITIS ArticleRodoman G.V., Sumedi I.R., Zyryanov S.K., Ivzhits M.A., Kurmashev A.F., Ionidi P.V., Putsman G.A., Kuchuk A.O.Antibiotiki i Khimioterapiya. Том 63. 2018. С. 18-27
PERSPECTIVE FOR USE OF THE RADIONUCLIDE DRUGS IN THE TREATMENT OF MALIGNANT TUMORS IN RUSSIA ArticleZyryanov S.K., Zatolochina K.E.Качественная клиническая практика. 2018. С. 51-57
PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY ArticleBobrova O.P., Dyhno Y.A., Shnayder N.A., Petrova M.M., Zyryanov S.K.Siberian Journal of Oncology. Том 17. 2018. С. 94-100
PHARMACOECONOMIC ASSESSMENT OF DUAL BRONCHODILATION THERAPY IN PATIENTS WITH COPD ArticleZyryanov S.K., D'yakov I.N.Pulmonologiya. Том 28. 2018. С. 61-68
GENETICALLY ENGINEERED DRUGS FOR TREATMENT OF BRONCHIAL ASTHMA: RECENT ACHIEVEMENTS ArticleZyryanov S.K., Butranova O.I.Pulmonologiya. Том 28. 2018. С. 584-601
OPTIMIZATION OF EPILEPSY PHARMACOTHERAPY BASED ON A PERSONALIZED APPROACH TO DRUG SAFETY ASSESSMENT ArticleBochanova E.N., Shnayder N.A., Zyryanov S.K., Gusev S.D., Nasyrova R.F.Доктор.Ру. 2018. С. 13-18
GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION? ArticleUshkalova E.A., Zyryanov S.K., Zatolochina K.E.Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Том 10. 2018. С. 75-80
MODERN PROBLEMS OF SURGICAL INFECTIONS OF THE SKIN AND SOFT TISSUES CAUSED BY MRSA, AND THE WAYS OF THEIR SOLUTION ArticleZyryanov S.K., Sychyov I.N.Хирург. 2018. С. 31-43
GCP INSPECTION BY ROSZDRAVNADZOR ArticleBelousov D.Yu., Zyryanov S.K., Kolbin A.S., Karpenko L.I., Rogov E.S.Качественная клиническая практика. 2018. С. 66-76
LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE ArticleZYRYANOV S.K., ZATOLOCHINA K.E., ASETSKAYA I.L.Antibiotiki i Khimioterapiya. Том 63. 2018. С. 46-51
IN VITRO EQUIVALENCE EVALUATION OF BETAHISTINE GENERIC MEDICINAL PRODUCTS AS A TOOL POTENTIALLY DETERMINING THE EFFICACY OF PHARMACOTHERAPY [OTSENKA ÉKVIVALENTNOSTI IN VITRO VOSPROIZVEDENNYKH PREPARATOV BETAGISTINA KAK INSTRUMENTA, POTENTSIAL'NO OPREDELIAIUSHCHEGO ÉFFEKTIVNOST' FARMAKOTERAPII] ArticleZyryanov S.K., Butranova O.I., Ramenskaya G.V., Gildeeva G.N., Shohin I.E.Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Том 118. 2018. С. 43-48
PHARMACOVIGILANCE SYSTEM IN EURASIAN ECONOMIC UNION ArticleAsetskaya I.L., Zyryanov S.K., Kolbin A.S., Belousov D.Yu.Качественная клиническая практика. 2018. С. 53-72
CLINICO-PHARMACOLOGICAL CHARACTERISTICS OF OPIOID DRUG-DRUG INTERACTIONS IN CANCER PATIENTS WITH CHRONIC PAIN SYNDROME ArticleBobrova O.P., Shnayder N.A., Zyryanov S.K., Dykhno Y.A., Petrova M.M., Nasyrova R.F.Siberian Journal of Oncology. Том 17. 2018. С. 114-122
ФАРМАКОЭКОНОМИЧЕСКОЕ ИССЛЕДОВАНИЕ ПРЕПАРАТОВ, ПРИМЕНЯЕМЫХ ПРИ ЛЕЧЕНИИ ПСОРИАЗА СРЕДНЕТЯЖЕЛОЙ И ТЯЖЕЛОЙ СТЕПЕНИ У ПАЦИЕНТОВ С НЕЭФФЕКТИВНОСТЬЮ БАЗОВОЙ СИСТЕМНОЙ ТЕРАПИИ ArticleЗырянов С.К., Белоусов Д.Ю., Чеберда А.Е.Клиническая фармакология и терапия. Том 27. 2018. С. 91-97
PHARMACOECONOMIC ANALYSIS OF AFATINIB AND GEFITINIB FOR THE TREATMENT OF LUNG CANCER ArticleFedyayev D.V., Zyryanov S.K.Medical Technologies. Assessment and Choice. 2018. С. 68-84
SELECTION OF MODERN P2Y12 INHIBITOR AS A PART OF DUAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON PRASUGREL ArticleZyryanov S.K., Baibulatova E.A.Лечебное дело. 2018. С. 50-61